349 related articles for article (PubMed ID: 23877352)
1. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
[TBL] [Abstract][Full Text] [Related]
2. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
[TBL] [Abstract][Full Text] [Related]
3. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.
Gupta A; Dhiman RK; Kumari S; Rana S; Agarwal R; Duseja A; Chawla Y
J Hepatol; 2010 Nov; 53(5):849-55. PubMed ID: 20675008
[TBL] [Abstract][Full Text] [Related]
4. Minimal hepatic encephalopathy impairs fitness to drive.
Wein C; Koch H; Popp B; Oehler G; Schauder P
Hepatology; 2004 Mar; 39(3):739-45. PubMed ID: 14999692
[TBL] [Abstract][Full Text] [Related]
5. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
[TBL] [Abstract][Full Text] [Related]
6. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
8. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
9. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
[TBL] [Abstract][Full Text] [Related]
10. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
[TBL] [Abstract][Full Text] [Related]
11. Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis.
Luo M; Hu FR; Xin RJ; Yao L; Hu SJ; Bai FH
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):797-807. PubMed ID: 35942803
[TBL] [Abstract][Full Text] [Related]
12. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
13. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
14. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
15. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
16. The otologic microbiome: a study of the bacterial microbiota in a pediatric patient with chronic serous otitis media using 16SrRNA gene-based pyrosequencing.
Liu CM; Cosetti MK; Aziz M; Buchhagen JL; Contente-Cuomo TL; Price LB; Keim PS; Lalwani AK
Arch Otolaryngol Head Neck Surg; 2011 Jul; 137(7):664-8. PubMed ID: 21768410
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
[TBL] [Abstract][Full Text] [Related]
18. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
19. Linkage of gut microbiome with cognition in hepatic encephalopathy.
Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
[TBL] [Abstract][Full Text] [Related]
20. Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis.
Haraguchi M; Miuma S; Masumoto H; Ichikawa T; Kanda Y; Sasaki R; Fukushima M; Miyaaki H; Taura N; Nakao K
Hepatol Int; 2019 Jul; 13(4):482-489. PubMed ID: 31290070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
